Nguyen H Tran - Department of Oncology, Mayo Clinic

基本信息

浏览量：4

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 72 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Real-world (RW) Experience with Atezolizumab + Bevacizumab (A+B) for the Treatment of Unresectable HCC (uhcc): A Multicenter Study

Maen Abdelrahim,Abdullah Esmail, Richard D. Kim,Sukeshi Patel Arora,Junaid Arshad, Ioannis Kournoutas, Conor O'Donnell,Todor Totev,Amie Tan, Fan Mu, Shravanthi M. Seshasayee,Sairy Hernandez,Nguyen H. Tran

Journal of Clinical Oncologyno. 4_suppl (2025): 537-537

引用0浏览0引用

Long-term Outcomes and Surgical Conversion Following Immunotherapy in MSI-H Biliary Tract Cancers

Priyanshi Shah, Anina Peersen,Amit Mahipal,Fang-Shu Ou,Nguyen H. Tran

Journal of Clinical Oncologyno. 4_suppl (2025): 592-592

引用0浏览0引用

Real-world Impact of Matched Targeted Therapy on Survival in Advanced Biliary Tract Cancer: an International Collaborative Study

Binbin Zheng-Lin, Celine Hoyek,Heidi E. Kosiorek,Oluseyi Abidoye,Cody Eslinger,Mohamad Bassam Sonbol,Christina Wu,Nguyen H. Tran,Hani M. Babiker,Lewis R. Roberts,Takayuki Yoshino,Masafumi Ikeda,Chigusa Morizane, Hideaki Bando, Yoshiaki Nakamura,Takao Fujisawa,Daniel H. Ahn,Mitesh J. Borad,Taro Shibuki,Tanios S. Bekaii-Saab

Journal of Clinical Oncologyno. 4_suppl (2025): 536-536

引用0浏览0引用

Definitive Local Therapy in Solitary Liver Metastatic Anal Squamous Cell Carcinoma

Teerada Siripoon, Conor O'Donnell,Michael H. Storandt, Patrick Starlinger,Nguyen H. Tran, Thomas D. Atwell,Krishan Jethwa, Zhaohui Jin

Journal of Clinical Oncologyno. 4_suppl (2025): 5-5

引用0浏览0引用

Genomic Alterations As Predictive Biomarkers for Cancer-Associated Thrombosis (CAT) in Biliary Tract Cancer (BTC)

Angelo Pirozzi, Celine Hoyek,Binbin Zheng-Lin,Naohiro Okano,Oluseyi Abidoye,Cody Eslinger,Hani M. Babiker,Umair Majeed,Nguyen H. Tran,Lorenza Rimassa,Tanios S. Bekaii-Saab, Surbhi Shah,Mitesh J. Borad

Journal of Clinical Oncologyno. 4_suppl (2025): 634-634

引用0浏览0引用

Patient (pt) Characteristics, Treatment Patterns, and Outcomes in Unresectable Hepatocellular Carcinoma (uhcc) Treated with First-Line (1L) Systemic Therapy in the United States (US)

Nguyen H. Tran,Scott A. Soefje, Nivedita Rangarajan, K Purushotham, Mihika Nadig,Tyler E. Wagner, Stephen J. Valerio, Rye Anderson, Jody C. Olson

Journal of Clinical Oncologyno. 4_suppl (2025): 572-572

引用0浏览0引用

Clinical Outcome after Complete Response with Immunotherapy in Hepatocellular Carcinoma

Pin-Jung Chen, Ioannis Kournoutas, Alison Sanford,Naomy Kim, Hasmik Adetyan,Mohammad Saeid Rezaee-Zavareh, Alexander Kuo,Walid Ayoub, Emily Kaymen,Andrew Eugene Hendifar,Nguyen H. Tran, Ju Dong Yang

Journal of Clinical Oncologyno. 4_suppl (2025): 573-573

引用0浏览0引用

Association Between Immune-Related Adverse Events and Prognosis after Immune Checkpoint Inhibitor in Hepatocellular Carcinoma: A Meta-Analysis and Systematic Review

Soo Young Hwang,Mohammad Saeid Rezaee-Zavareh, Abdelrahman M Attia, Emily Kaymen,Nguyen H. Tran,Ghassan K. Abou-Alfa,Amit Singal, Ju Dong Yang

Journal of Clinical Oncologyno. 4_suppl (2025): 566-566

引用0浏览0引用

First Line Atezolizumab + Bevacizumab (atezo/bev) or Durvalumab ± Tremelimumab (durva±treme) in Unresectable Hepatocellular Carcinoma (HCC): A Real World, Multi-Institutional Retrospective Cohort Study

Ioannis Kournoutas,Paulina S Marell, Anina Peersen, Garima Gupta, Mehmet Akce, Ju Dong Yang, Pin-Jung Chen,Nikolas Naleid,Amit Mahipal,Vaibhav Sahai,Scott Thompson, Zhaohui Jin, Sudhakar Venkatesh,Mitesh J. Borad,Hani M. Babiker,Tanios S. Bekaii-Saab,Robert R. McWilliams,Thorvardur Ragnar Halfdanarson,Fang-Shu Ou,Nguyen H. Tran

Journal of Clinical Oncologyno. 4_suppl (2025): 532-532

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn